0000899243-20-033801.txt : 20201214 0000899243-20-033801.hdr.sgml : 20201214 20201214203547 ACCESSION NUMBER: 0000899243-20-033801 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Connell Daniel P CENTRAL INDEX KEY: 0001752965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 201387893 MAIL ADDRESS: STREET 1: 610 MAIN STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 1 0001664106 LogicBio Therapeutics, Inc. LOGC 0001752965 O'Connell Daniel P C/O LOGICBIO THERAPEUTICS, INC. 65 HAYDEN AVENUE, FLOOR 2 LEXINGTON MA 02421 1 0 0 0 Common Stock 2020-12-10 4 M 0 2513 A 2513 D Restricted Stock Units 2020-12-10 4 M 0 2513 0.00 D Common Stock 2513 0 D Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company"). Pursuant to action taken by the Company's Board of Directors on December 10, 20202, the RSUs vested in full on the date thereof. Matthias Jaffe, as Attorney-in-Fact 2020-12-14